Abstract
Acute Myeloid Leukemia is a chronic and disabling disease. To assist with the right decisions about the treatment of patients, a prognosis is made concerning the risk of the disease, in three groups: favorable, intermediate, and unfavorable. This classification is commonly used as an aid in customizing therapeutic decisions. However, the current ranking is very conservative. Patients with…